Back
SpringWorks Therapeutics Stock Price Chart

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
29
SWTX
SpringWorks Therapeutics
Last Price:
$46.47
Seasonality Move:
-7.9%
7 Day Trial
ALL ACCESS PASS
$
7

The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.24 | Buy |
20-day SMA: | 46.23 | Buy |
50-day SMA: | 44.36 | Buy |
200-day SMA: | 40.06 | Buy |
8-day EMA: | 46.25 | Buy |
20-day EMA: | 45.59 | Buy |
50-day EMA: | 44.92 | Buy |
200-day EMA: | 41.86 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.73 | Buy |
Relative Strength Index (14 RSI): | 59.81 | Buy |
Chaikin Money Flow: | 5677063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.08 - 47.56) | Buy |
Bollinger Bands (100): | (37.35 - 51.41) | Buy |
SpringWorks Therapeutics Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 46.48 while SWTX 8-day simple moving average is 46.24, which is a Buy signal.
-
The stock price of SWTX is 46.48 while SpringWorks Therapeutics 20-day SMA is 46.23, which makes it a Buy.
-
SpringWorks Therapeutics 50-day simple moving average is 44.36 while SWTX share price is 46.48, making it a Buy technically.
-
SWTX stock price is 46.48 and SpringWorks Therapeutics 200-day simple moving average is 40.06, creating a Buy signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
29
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $46.48. The Score for SWTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
3.5B
Price in USD:
46.48
Share Volume:
5.9M
SpringWorks Therapeutics 52-Week Range
52-Week High:
62.00
52-Week Low:
28.21
Sell
29
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 46.48 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 46.48 while SWTX 8-day exponential moving average is 46.25, which is a Buy signal.
-
The stock price of SWTX is 46.48 while SpringWorks Therapeutics 20-day EMA is 45.59, which makes it a Buy.
-
SpringWorks Therapeutics 50-day exponential moving average is 44.92 while SWTX share price is 46.48, making it a Buy technically.
-
SWTX stock price is 46.48 and SpringWorks Therapeutics 200-day simple moving average is 41.86, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $3.01 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is 0.73, suggesting SpringWorks Therapeutics is a Buy
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 59.81, which suggest SpringWorks Therapeutics is overbought
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (43.08 - 47.56), which suggest SpringWorks Therapeutics is a Buy
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (37.35 - 51.41), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.